| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
and ß Are Differentially Expressed in Developing Human Bone1
Address all correspondence and requests for reprints to: Dr. Sharyn Bord, University of Cambridge School of Clinical Medicine, Addenbrookes Hospital, Box 157, Cambridge, United Kingdom CB2 2QQ. E-mail: sb201{at}cam.ac.uk
Estrogen plays an essential role in the development and maintenance of
the skeleton; its effects are mediated via interactions with two
estrogen receptor (ER) subtypes,
and ß. The aim of this study was
to establish the cellular distribution of ER
and ERß in neonatal
human rib bone. ER
and ERß immunoreactivity was seen in
proliferative and prehypertrophic chondrocytes in the growth plate,
with lower levels of expression in the late hypertrophic zone.
Different patterns of expression of the two ERs were seen in bone. In
cortical bone, intense staining for ER
was observed in osteoblasts
and osteocytes adjacent to the periosteal-forming surface and in
osteoclasts on the opposing resorbing surface. In cancellous bone,
ERß was strongly expressed in both osteoblasts and osteocytes,
whereas only low expression of ER
was seen in these areas. Nuclear
and cytoplasmic staining for ERß was apparent in osteoclasts. These
observations demonstrate distinct patterns of expression for the two ER
subtypes in developing human bone and indicate functions in both the
growth plate and mineralized bone. In the latter, ER
is
predominantly expressed in cortical bone, whereas ERß shows higher
levels of expression in cancellous bone.
This article has been cited by other articles:
![]() |
I. Mohamed and J. K Yeh Alfacalcidol prevents aromatase inhibitor (Letrozole)-induced bone mineral loss in young growing female rats J. Endocrinol., August 1, 2009; 202(2): 317 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ogita, M. T. Rached, E. Dworakowski, John. P. Bilezikian, and S. Kousteni Differentiation and Proliferation of Periosteal Osteoblast Progenitors Are Differentially Regulated by Estrogens and Intermittent Parathyroid Hormone Administration Endocrinology, November 1, 2008; 149(11): 5713 - 5723. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Saxon, A. G. Robling, A. B. Castillo, S. Mohan, and C. H. Turner The skeletal responsiveness to mechanical loading is enhanced in mice with a null mutation in estrogen receptor-beta Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E484 - E491. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Syed, D. G. Fraser, T. C. Spelsberg, C. J. Rosen, A. Krust, P. Chambon, J. L. Jameson, and S. Khosla Effects of Loss of Classical Estrogen Response Element Signaling on Bone in Male Mice Endocrinology, April 1, 2007; 148(4): 1902 - 1910. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.J. Mao, W.V. Giannobile, J.A. Helms, S.J. Hollister, P.H. Krebsbach, M.T. Longaker, and S. Shi Craniofacial Tissue Engineering by Stem Cells Journal of Dental Research, November 1, 2006; 85(11): 966 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vanderschueren, K. Venken, J. Ophoff, R. Bouillon, and S. Boonen Sex Steroids and the Periosteum--Reconsidering the Roles of Androgens and Estrogens in Periosteal Expansion J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 378 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ichikawa, D. L. Koller, M. Peacock, M. L. Johnson, D. Lai, S. L. Hui, C. C. Johnston, T. M. Foroud, and M. J. Econs Polymorphisms in the Estrogen Receptor {beta} (ESR2) Gene Are Associated with Bone Mineral Density in Caucasian Men and Women J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5921 - 5927. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khosla, B. L. Riggs, R. A. Robb, J. J. Camp, S. J. Achenbach, A. L. Oberg, P. A. Rouleau, and L. J. Melton III Relationship of Volumetric Bone Density and Structural Parameters at Different Skeletal Sites to Sex Steroid Levels in Women J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5096 - 5103. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Monroe, F. J. Secreto, M. Subramaniam, B. J. Getz, S. Khosla, and T. C. Spelsberg Estrogen Receptor {alpha} and {beta} Heterodimers Exert Unique Effects on Estrogen- and Tamoxifen-Dependent Gene Expression in Human U2OS Osteosarcoma Cells Mol. Endocrinol., June 1, 2005; 19(6): 1555 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Garcia Palacios, L. J. Robinson, C. W. Borysenko, T. Lehmann, S. E. Kalla, and H. C. Blair Negative Regulation of RANKL-induced Osteoclastic Differentiation in RAW264.7 Cells by Estrogen and Phytoestrogens J. Biol. Chem., April 8, 2005; 280(14): 13720 - 13727. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Fabian and B. F. Kimler Selective Estrogen-Receptor Modulators for Primary Prevention of Breast Cancer J. Clin. Oncol., March 10, 2005; 23(8): 1644 - 1655. [Full Text] [PDF] |
||||
![]() |
L. Gennari, D. Merlotti, V. De Paola, A. Calabro, L. Becherini, G. Martini, and R. Nuti Estrogen Receptor Gene Polymorphisms and the Genetics of Osteoporosis: A HuGE Review Am. J. Epidemiol., February 15, 2005; 161(4): 307 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Angelopoulos, V Barbounis, S Livadas, D Kaltsas, and G Tolis Effects of estrogen deprivation due to breast cancer treatment Endocr. Relat. Cancer, September 1, 2004; 11(3): 523 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakano, Y. Nagamatsu, and Y. Ohshima cGMP and a germ-line signal control body size in C. elegans through cGMP-dependent protein kinase EGL-4 Genes Cells, September 1, 2004; 9(9): 773 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson Androgens and Bone Endocr. Rev., June 1, 2004; 25(3): 389 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. Chen, M. Delannoy, C. Cooke, and J. D. Yager Mitochondrial localization of ER{alpha} and ER{beta} in human MCF7 cells Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E1011 - E1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Centrella, T. L. McCarthy, W.-Z. Chang, D. C. Labaree, and R. B. Hochberg Estren (4-Estren-3{alpha},17{beta}-diol) Is a Prohormone that Regulates Both Androgenic and Estrogenic Transcriptional Effects through the Androgen Receptor Mol. Endocrinol., May 1, 2004; 18(5): 1120 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Khosla, B. L. Riggs, E. J. Atkinson, A. L. Oberg, C. Mavilia, F. Del Monte, L. J. Melton III, and M. L. Brandi Relationship of Estrogen Receptor Genotypes to Bone Mineral Density and to Rates of Bone Loss in Men J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1808 - 1816. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. I. L. Modder, A. Sanyal, A. E. Kearns, J. D. Sibonga, E. Nishihara, J. Xu, B. W. O'Malley, E. L. Ritman, B. L. Riggs, T. C. Spelsberg, et al. Effects of Loss of Steroid Receptor Coactivator-1 on the Skeletal Response to Estrogen in Mice Endocrinology, February 1, 2004; 145(2): 913 - 921. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. McDougall, M. J. Perry, R. L. Gibson, S. M. Colley, K. S. Korach, and J. H. Tobias Estrogen Receptor-{alpha} Dependency of Estrogen's Stimulatory Action on Cancellous Bone Formation in Male Mice Endocrinology, May 1, 2003; 144(5): 1994 - 1999. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Riggs and L. C. Hartmann Selective Estrogen-Receptor Modulators -- Mechanisms of Action and Application to Clinical Practice N. Engl. J. Med., February 13, 2003; 348(7): 618 - 629. [Full Text] [PDF] |
||||
![]() |
K. E. McDougall, M. J. Perry, R. L. Gibson, J. M. Bright, S. M. Colley, J. B. Hodgin, O. Smithies, and J. H. Tobias Estrogen-induced osteogenesis in intact female mice lacking ERbeta Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E817 - E823. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |